Microscopic intramural spread in patients with rectal cancer after neoadjuvant chemoradiation
69% of patients do not retain MIS post-neoadjuvant therapy. Knowledge of tumor thickness seems crucial for patient selection for CXB.
Authors
- Heike I. Grabsch (ORCID: https://orcid.org/0000-0001-9520-6228)
- Jarno Melenhorst (ORCID: https://orcid.org/0000-0002-1495-4003)
- Danny Goudkade
- Evert J. Van Limbergen (ORCID: https://orcid.org/0000-0002-6405-322X)
- Murillo Bellezzo (ORCID: https://orcid.org/0000-0001-5273-0003)
- An-Sofie Verrijssen (ORCID: https://orcid.org/0000-0002-5193-2831)
- Iryna Samarska (ORCID: https://orcid.org/0000-0003-4092-0672)
- Frank Verhaegen (ORCID: https://orcid.org/0000-0001-8470-386X)
- Gabriel Paiva Fonseca (ORCID: https://orcid.org/0000-0002-8087-1193)
- Ruud Houben (ORCID: https://orcid.org/0000-0001-6869-9733)
- Maaike Berbée
Institutions
- Radboud University Nijmegen (NL)
- Maastricht University Medical Centre (NL)
- Catharina Ziekenhuis (NL)
- Zuyderland Medisch Centrum (NL)
- Maastro Clinic (NL)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1016/j.ctro.2025.100963
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00